Pituitary Adenoma Clinical Trial
Official title:
A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas
5-Aminolevulinic Acid (5-ALA) was approved by the FDA as an intraoperative optical imaging agent in patients with suspected high-grade gliomas (HGGs) in 2017. The investigators plan to administer 5-ALA to patients with pituitary tumors to demonstrate whether it can be used as an intraoperative optical imaging agent for this pathology. Overall, this pilot study will afford the overall opportunity to improve surgical management and advancement of the science of neurological and neuroendocrine disease.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04081701 -
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
|
Phase 4 | |
| Completed |
NCT01689064 -
Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
|
N/A | |
| Recruiting |
NCT04611685 -
Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas
|
N/A | |
| Completed |
NCT04212793 -
Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
|
Phase 1 | |
| Recruiting |
NCT02709863 -
Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests
|
N/A | |
| Completed |
NCT01465672 -
Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
|
N/A | |
| Terminated |
NCT00798057 -
Proton Radiation Therapy for Pituitary Adenoma
|
N/A | |
| Completed |
NCT01504399 -
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||
| Recruiting |
NCT01556230 -
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
|
||
| Completed |
NCT04074642 -
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
|
N/A | |
| Recruiting |
NCT04621565 -
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
|
N/A | |
| Completed |
NCT04076046 -
Multicentric Prospective Validation of the Zurich Pituitary Score
|
||
| Not yet recruiting |
NCT03714763 -
Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
|
N/A | |
| Recruiting |
NCT05822817 -
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
|
Phase 4 | |
| Not yet recruiting |
NCT04569591 -
Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
|
N/A | |
| Recruiting |
NCT03164148 -
Heart Rate Variability (HRV) in Pituitary Adenoma
|
N/A | |
| Completed |
NCT04284605 -
Effects Exercise Training in Patients With Pituitary Adenoma
|
N/A | |
| Terminated |
NCT03515603 -
Endocrine Outcome of Surgery for Pituitary Adenoma
|
N/A | |
| Not yet recruiting |
NCT04863456 -
Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement
|
N/A | |
| Active, not recruiting |
NCT03465618 -
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
|
Phase 1 |